1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsTranslational Platforms is sponsored by National Research Foundation, Singapore (NRF). Translational Platforms. Funding program from the National Research Foundation, Singapore.
Get alerted about grants like this
Save a search for “National Research Foundation, Singapore (NRF)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
A Singapore Government Agency Website  Official website links end with . gov.sg Government agencies communicate via websites (e.g. go. gov.sg/open) .
Secure websites use HTTPS lock ( ) or https:// as an added precaution. Share sensitive information only on official, secure websites. National Research Infrastructure To support companies on their innovation journey, we have set up translational platforms to enable enterprises to better tap on the ideas, expertise, and science and technology capabilities of our public research institutions and other innovation ecosystem players.
Existing translational platforms have been set up in areas such as drug development, clinical diagnostics, and additive manufacturing (see examples below). In RIE2025 , we will catalyse industry growth in sectors where we have developed R&D strengths, and build collaborative and synergistic ecosystems that will foster cross-pollination of knowledge.
Diagnostics Development Hub Diagnostics Development (DxD) Hub was established in 2014 as a national platform to bridge the gap in productisation of diagnostic products and services, and de-risk the adoption of publicly-funded diagnostics intellectual properties by the industry.
Over the years, DxD Hub has developed core capabilities in diagnostic product development and digital health that enables it to create ready-to register diagnostics solutions with effective go-to-market strategies. DxD Hub also hosts the Digital Health Accelerator, a collaboration between Singapore’s Ministry of Health, Public Health Institutions, and ASTAR to support the adoption and scaling of digital health solutions.
With its deep understanding of the market, DxD Hub has developed effective partnerships with both public and private sector organisations. Rising to the challenge of supporting Singapore during the COVID-19 pandemic, DxD Hub accelerated the development and adoption of a number of COVID-19 testing solutions with end-to-end innovations such as deep throat saliva testing, improved automation, and AI enabled batch-reading.
In RIE2025, DxD Hub aims to expand its core competencies and capabilities and build into Integrated MedTech (IMT) and Digital Diagnostics (DDx). DxD Hub also supports the Diagnostics Incubator under the Programme for Research in Epidemic Preparedness and REsponse (PREPARE) initiative to focus on building just-in-time assembly of robust diagnostic prototypes in the event of a disease outbreak.
Experimental Drug Development Centre Established in 2019, The Experimental Drug Development Centre (EDDC) is a publicly-funded national platform for drug discovery and development, focused on developing therapeutics that save or improve the lives of patients in Singapore, Asia and around the world.
By collaboratively with public sector and industry partners, EDDC translates Singapore’s biomedical R&D into healthcare solutions, with a focus on Asian-prevalent diseases. EDDC has played an important role in supporting the local biotech ecosystem through strategic partnerships and contributed to translational research in cancer, infectious diseases (e.g. COVID-19), ophthalmology, fibrosis and other diseases.
In January 2023, the EDDC team got Investigational New Drug (IND) approval from the United States Food and Drug Administration (FDA) to start clinical trials for the first made-in-Singapore antibody-drug conjugate (ADC), EBC-129. This development was a joint effort together with the National Cancer Centre Singapore (NCCS), and ASTAR’s Bioprocessing Technology Institute (BTI), and the Institute of Molecular and Cell Biology (IMCB).
EBC-129 selectively kills cancer cells across a range of solid tumours, while sparing normal health cells, and could potentially address an unmet need for many patients. In RIE2025, EDDC aims to increase its impact by working with the Singapore ecosystem to advance and translate early stage drug discovery projects, build new capabilities and platforms, to transform human health.
National Additive Manufacturing Innovation Cluster Established in 2015, the National Additive Manufacturing Innovation Cluster (NAMIC) aims to accelerate the adoption of hybrid and digital additive manufacturing (AM) technologies under Singapore’s Manufacturing and Economy 2030 Vision, helping industries transform towards innovation and high value-added manufacturing using sustainably sourced, nature-based designs and cradle-to-cradle on-demand manufacturing.
NAMIC achieves this by focusing on value capture and creation through an industry sectorial engagement approach, leveraging on public-private partnerships and R&D investments, supporting translational research, and accelerating industry test-bedding towards commercial scale-up.
Companies such as Mencast and Sembcorp Marine have collaborated successfully with the Singapore University of Technology and Design (SUTD), ASTAR and NAMIC to develop and deploy large-format robotic 3D printing technologies for the design, repair and production of ship and offshore parts.
In RIE2025, NAMIC will continue to grow its international outreach, identifying and supporting deep-tech companies incorporating AM technologies seeking capital injection either through project joint-funding or its investor networks.
NAMIC will also work with both international and local standard and certification bodies to set out definitions, specifications and procedures for the design, performance and quality of materials used, and processes in AM technology adoption. National Research Infrastructure
Based on current listing details, eligibility includes: Researchers at eligible Singapore institutions (universities, research institutes, public sector agencies). See program guidelines for detailed eligibility. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies by program Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
EPSCoR Research Infrastructure Improvement Program: Focused EPSCoR Collaborations Program (FEC) is sponsored by U.S. National Science Foundation. The FEC program builds interjurisdictional collaborative teams of EPSCoR investigators in STEM focus areas. Projects are investigator-driven and must include researchers from at least two EPSCoR eligible jurisdictions with complementary expertise to address challenges. The program aims to drive discovery and build sustainable STEM capacity. Tennessee is an EPSCoR-eligible jurisdiction.
Engineering of Biomedical Systems (EBMS) Program is sponsored by U.S. National Science Foundation (NSF). The EBMS program supports fundamental and transformative research at the interface of engineering and biomedical sciences to solve biomedical problems. Projects should focus on high-impact, transformative methods and technologies, including the development of validated models (living or computational) of normal and pathological tissues and organ systems, and advanced biomanufacturing of three-dimensional tissues and organs.